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Abstract
Replication of reported associations is crucial to the investigation of complex disease. More than 100 SNPs have previously
been reported as associated with allergic rhinitis (AR), but few of these have been replicated successfully. To investigate the
general reproducibility of reported AR-associations in candidate gene studies, one Swedish (352 AR-cases, 709 controls) and
one Singapore Chinese population (948 AR-cases, 580 controls) were analyzed using 49 AR-associated SNPs. The overall
pattern of P-values indicated that very few of the investigated SNPs were associated with AR. Given published odds ratios
(ORs) most SNPs showed high power to detect an association, but no correlations were found between the ORs of the two
study populations or with published ORs. None of the association signals were in common to the two genome-wide
association studies published in AR, indicating that the associations represent false positives or have much lower effect-sizes
than reported.
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Introduction
Allergic rhinitis (AR) is the most common allergic disease
affecting more than 500 million people worldwide and is
characterized by nasal symptoms including sneezing, rhinorrhea
and nasal blockage. AR is also associated with an IgE-mediated
immune response against allergens [1]. The development of AR is
due to a complex interaction between both environmental and
genetic factors. The heritability for AR has been estimated to be as
high as 70–90% [2,3].
In AR a number of case-control and family-based association
studies as well as linkage studies have identified a number of
SNPs and chromosomal regions potentially associated with the
disease. Until 2010 an absolute majority of the genetic studies of
AR were candidate gene studies. The few exceptions were cases
of classical linkage analysis. In 2011 a genome-wide association
study (GWAS) [4] and a GWAS meta-study [5] were published
in addition to a number of candidate gene studies. Thus, the
current list of implicated SNPs is clearly dominated by results
from early candidate gene studies. In total, this has resulted in
more than 100 single nucleotide polymorphisms (SNPs) reported
as associated with AR. However, the investigations that have
resulted in this list of SNPs are very heterogeneous with respect
to sample sizes, type of study populations and phenotype
definitions.
Case-control association tests have become a very popular
method to search for genetic variants in linkage disequilibrium
with risk factors (http://www.wtccc.org.uk). Today, a large
number of traits/diseases have been investigated using this
technique e.g. diabetes, schizophrenia, coronary diseases and
various forms of cancer. Over the past 15 years standards have
shifted towards larger sample sizes of both cases and controls. It
has also become apparent that an association can only be
considered reliable if it has been properly replicated. In a study
based on self-reported data on 50 medical phenotypes from a
cohort of more than 20 000 genotyped individuals, approx-
imately 75% of expected associations were successfully replicat-
ed [6]. One observation was that different traits and diseases
varied drastically with respect to their reproducibility of
reported associations, probably reflecting inflation of the effects
in some reports and differences among diseases in the likelihood
of proper disease classification. In a systematic investigation
aiming for replication of reported risk-associated polymorphisms
in prostate cancer, 18 out of 50 SNPs were successively
replicated [7], whereas only 10 out of 93 and 5 out of 44 SNPs
were replicated in two different replication studies in asthma
[8,9]. Thus, in the ongoing investigation of a disease it is of
importance to monitor the general reproducibility of reported
associations. In AR no such evaluation has previously been
performed.
In this study we have investigated the general reproducibility of
reported SNP associations from previous candidate gene studies
using two different study populations, one Swedish and one
Singapore Chinese. The result shows poor reproducibility of AR
SNP associations.
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Results and Discussion
To investigate the reproducibility of reported associations from
previous candidate gene studies in AR, two study populations, one
from Sweden (352 AR-cases, 709 controls) and one from
Singapore (948 AR-cases, 580 controls), were analyzed using a
set of 49 SNPs reported as associated with AR. These SNPs
constitute a subset of a total of 116 AR-associated SNP markers
compiled from 52 different studies (Table S1 and S2). The present
study investigates the same phenotype (AR) and the same SNP
markers that were reported in the initial studies.
Association test results are summarized in Table 1, Table S3,
S4, S5 and S6. In the Singapore Chinese population (CP), 45
SNPs were analyzed. The distribution of P-values showed a very
good fit to the expected distribution in the absence of an effect.
The lowest P-value was 0.003 for rs3761547 in the FOXP3 gene
and no SNP showed a false discovery rate (Q-value) below 0.1. The
49 SNPs analyzed in the Swedish population (SP) also showed a
good fit to the expected distribution of P-values in the absence of
an effect. There was, however, a slight overrepresentation of P-
values below 0.01. The lowest P-value (P= 0.00084, Q= 0.033)
was found for rs4732416 in CCL24 when testing for genotypic
effects. However, in the corresponding test of allelic effects the P-
value was 0.75 and two additional SNPs in this gene showed no
significant associations. In the FOXJ1-gene the rs880213 SNP
showed P-values below 0.01 both at the allele and genotype levels.
The corresponding Q-values were 0.28 and 0.085. Significant P-
values were observed in both populations for rs20541 in IL13 and
for rs13340504 in CCL24. In both cases, however, significant P-
values were observed for the association test in CP and the skin
prick test (SPT) in SP. Thus, the overall pattern of P- and Q-values
in the present study indicates that very few if any of the SNPs are
associated with AR.
The lack of replication can have several explanations: the
previously reported effects may simply not be present in the
populations investigated here, the original reports may be false
positive associations (type I error), or the reported odds ratios
(ORs) may be inflated due to chance (the ‘‘winners curse’’ effect).
Also, the use of different clinical definitions compared to the
original reports resulting in enrichment of cases with different
clinical subtypes makes replication difficult. In addition, interac-
tions with other factors such as age, sex and urban/rural residency
may have an impact on replication. To investigate the ability of
the present study to detect the previously reported associations, we
estimated the power for the allele-based test in the present
investigation. Given calculated or published ORs and the sample
sizes used in the present study, the power was calculated at
significance levels 0.05 and 0.001. The results are shown in Table 2
where most SNPs show high power to detect an association. The
expected number of significant P-values is calculated as the sum of
the power estimates with standard deviation = (gpoweri(1-poweri))
1/
2. The expected number varies between 16.3 and 22.3 with
standard deviations between 1.0 and 1.8. Since the observed
number of significant P-values varies between 0 and 2 (Table 1),
the expected numbers exceed the observed by many standard
deviations, i.e. if the published ORs would have been true a
number of significant results would have been expected. However,
it is not an uncommon observation that early association studies
report highly inflated ORs. Although the observed results are not
surprising, the present investigation is the first systematic study of
this aspect in AR.
If the originally reported significant ORs are due to a ‘‘winners
curse’’ effect, the power in our analysis may be insufficient. If this
is true, an effect could perhaps still be traced via a correlation of
effects between investigations. Spearman correlation coefficients
were therefore calculated from the ORs for allelic effects for the
different sets of data. Comparing data from the SP with published
data from the other European populations, a non-significant result
was obtained with a correlation coefficient of 0.08 (P= 0.84). In
the corresponding comparison between data obtained from the CP
and published data from other Asian populations the correlation
coefficient was higher but still non-significant (R= 0.33 and
P= 0.19). Finally, the concordance between SP and CP was
calculated. Also this comparison gave a low and non-significant
correlation coefficient (R= 0.03 and P=0.87).
A third strategy to investigate potential associations would be to
test for identical trends among SNPs. This was done by calculating
the number of concordant SNPs, i.e. SNPs for which both ORs
were either larger than 1 or less than 1, as well as the number of
discordant SNPs, i.e. SNPs where one OR was less than 1 and the
other was larger than 1. In the comparison between the Swedish
and Singapore results, 23 SNPs were concordant and 20 were
Table 1. Observed and expected numbers of P-values for the different association tests in the Swedish population (n = 1061) and
the Singapore Chinese population (n = 1528).
P-value range Swedish population Singapore Chinese population
Allele Genotype Birch Timothy Total Allele Genotype B. tropicalis D. pteronyssinus Total
1.0–0.1 Obs/Exp 45/44 45/44 42/43 42/43 174/174 41/41 39/41 43/41 41/41 166/162
Q-values 0.88–0.99 0.59–0.74 0.73–0.97 0.50–0.80 0.50–0.99 0.88–0.97 0.53–0.77 0.76–0.90 0.42–0.97 0.42–0.97
0.1–0.05 Obs/Exp 3/2.5 2/2.5 4/2.4 4/2.4 13/9.8 2/2.3 4/2.3 1/2.3 1/2.3 7/9.2
Q-values 0.88–0.93 0.59 0.73 0.45–0.49 0.45–0.93 0.88 0.46 0.76 0.42 0.42–0.88
0.05–0.01 Obs/Exp 0/2.0 0/2.0 1/1.9 1/1.9 2/7.8 2/1.8 2/1.8 0/1.8 2/1.8 6/7.2
Q-values 2 2 0.73 0.45 0.45–0.73 0.60 0.46 2 0.15–0.19 0.15–0.60
0.01–0.001 Obs/Exp 1/0.44 1/0.44 1/0.43 1/0.43 4/1.7 0/0.40 0/0.40 2/0.40 1/0.40 3/1.6
Q-values 0.28 0.085 0.23 0.12 0.085–0.28 2 2 0.11–0.13 0.14 0.11–0.14
0.001 Obs/Exp 0/0.05 1/0.050 0/0.050 0/0.050 1/0.20 0/0.040 0/0.040 0/0.040 0/0.040 0/0.16
Q-values 2 0.033 2 2 2 2 2 2 2 2
Obs/Exp =Observed number of P-values/Expected number of P-values in the absence of effect.
Q-values =Observed Q-values calculated according to Storey JD (2002) A direct approach to false discovery rates. J R Stat Soc Series B Stat Methodol 64:479–498.
doi:10.1371/journal.pone.0053975.t001
Poor Reproducibility in Allergic Rhinitis
PLOS ONE | www.plosone.org 2 January 2013 | Volume 8 | Issue 1 | e53975
discordant, which of course is not significantly different from equal
proportions. Thus, even at this basic level no sign of effects of the
investigated SNPs could be detected.
Several GWAS have been performed to identify genetic variants
for asthma and related phenotypes whereas only one study has
been performed aiming specifically for AR [4]. In the latter no
associations were detected at a genome-wide significance level, and
only two at a suggestive significance level. A genome-wide meta-
analysis based on self-reported phenotyping identified few genetic
variants associated with AR in spite of analyzing 2.2 million SNPs
in close to 4000 AR cases and 9000 controls [5]. Only one locus
reached genome-wide significance and six suggestive loci were
identified. When this data set was used in a candidate gene
approach analyzing 164 genes only one locus was identified as
suggestive for the AR phenotype [5]. Comparing these two GWAS
there were no significant association signals in common, and the
ORs identified for the significant SNPs were in the size ranges 0.6–
1.4 and 1.1–1.3, respectively, in the two studies [4,5]. This is in
contrast to the previously reported associations listed in Table S1
and S2 where many show much stronger effects (OR=0.16–7.8).
In addition, none of these associations are detected in the GWAS
described above.
In conclusion, the overall pattern of P- and Q-values indicates
that very few, if any, of the 49 investigated SNPs are significantly
associated with AR in our populations. If associations do exist they
must have much lower effect sizes than reported. This is in
Table 2. Power estimates in present investigation given odds ratios extracted or calculated from published data.




(SP){ Power (CP){ Reference*
0.05 0.001 0.05 0.001
IL28RA rs7525481 g.32349 G.A Korean 267; 559 0.74 0.72 0.20 0.98 0.76 [10]
FCGR2A rs1801274 R131R Turkish 180; 234 1.93 1.00 1.00 1.00 1.00 [11]
CD55 (DAF) rs10746463 Japanese 684; 346 0.73 0.86 0.40 2 2 [12]
CCR3 rs4987053 51T/C Japanese 151; 157 7.75 1.00 1.00 1.00 1.00 [13]
IL2 rs2069762 2330T/G German 318; 322 1.29 0.72 0.22 0.91 0.49 [14]
IL13 rs1800925 C-1112T Spanish 146; 50 0.16 1.00 1.00 1.00 1.00 [15]
IL13 rs20541 R130Q Spanish 146; 50 1.52 0.97 0.73 1.00 0.98 [15]
HAVCR2 rs1036199 4259G.T Korean 201; 319 1.54 0.98 0.75 0.16 0.00 [16]
CCL26 rs2302009 2497T.G Korean 178; 281 2.87 1.00 1.00 1.00 1.00 [17]
CCL24 rs2302004 179T.C Korean 178; 281 1.10 0.19 0.01 0.22 0.02 [17]
IL33 rs1929992 Japanese 170; 100 1.41 0.95 0.63 1.00 0.90 [18]
GATA3 rs1269486 Han Chinese 109; 112 0.35 1.00 1.00 1.00 0.97 [19]
MS4A2 rs569108 Glu237Gly Japanese 233; 100 1.47 0.17 0.01 0.99 0.81 [20]
IL18 rs187238 2137G.C Swiss 1105; 2953 1.12 0.20 0.01 0.17 0.01 [21]
IL18 rs187238 2137C German 25; 80 2.72* 1.00 1.00 1.00 1.00 [22]
RNASE3 rs2233860 Korean 440; 478 1.36 0.78 0.30 0.87 0.41 [23]
IL4R rs1805010 Ile50Val Japanese 145; 206 0.62 1.00 0.96 1.00 1.00 [24]
IL4R rs1805011 Glu375Ala Japanese 145; 206 0.35 1.00 1.00 1.00 1.00 [24]
NOD2 rs5743266 German 488; 978 0.82* 0.43 0.06 0.08 0.00 [25]
NOD2 rs2066842 German 488; 978 0.80* 0.49 0.08 0.08 0.00 [25]
NOD2 rs2066844 C2104T German 154; 1765 1.73* 0.53 0.13 2 2 [26]
NOD2 rs2066845 G2722C German 154; 1765 3.16* 0.87 0.46 2 2 [26]
CCL5 rs2280788 228C/G Korean 151; 278 1.58 0.43 0.08 0.98 0.78 [27]
CCL5 rs2107538 2403G/A Korean 151; 278 1.42 0.85 0.41 1.00 0.89 [27]
EPX rs2240815 3979A/G Czech 294; 319 1.28 0.76 0.27 0.85 0.39 [28]
FOXJ1 rs3192453 g.3375G.C Korean 295; 418 0.62 0.78 0.25 0.98 0.78 [29]
FOXJ1 rs880213 g. 2460C.T Korean 295; 418 0.64 0.89 0.43 0.95 0.64 [29]
ADAM33 rs2787094 Chinese Han 128; 151 4.01 1.00 1.00 1.00 1.00 [30]
ADAM33 rs2280089 12540C/T Japanese 95; 95 0.32 1.00 1.00 1.00 1.00 [31]
ADAM33 rs2280089 12540C/T Chinese Han 128; 151 1.91 1.00 0.98 1.00 0.99 [30]
ADAM33 rs2280090 12462C/T Japanese 95; 95 0.28 1.00 1.00 1.00 1.00 [31]
ADAM33 rs2280090 12462C/T Chinese Han 128; 151 0.40 1.00 0.99 1.00 1.00 [30]
ADAM33 rs511898 7575G/A Japanese 95; 95 0.60 1.00 0.96 1.00 1.00 [31]
{Odds ratios (OR) as reported in reference (*) or calculated for minor allele given published data.
{Power calculations at different levels of significance in the Swedish (SP) and the Singapore Chinese (CP) population. The significance level 0.001 corresponds
approximately to the Bonferroni correction level.
doi:10.1371/journal.pone.0053975.t002
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agreement with the results of the GWAS where reported effect
sizes are fairly modest. The results above do not exclude that
certain cases may represent true associations. Due to the necessary
compensation for the multiple testing involved, the larger the
number of SNPs that are included in a study, the harder it is to
detect true associations. The obvious candidates are of course the
SNPs with low P-values mentioned above. In these cases, the
likelihood of an association is strengthened if the ORs in CP, SP
and the original publication are concordant. This is not the case
for the SNPs in CCL24, FOXJ1 and IL33. The strongest case using
this criterion would be rs20541 in IL13 where there is complete
concordance in the direction of the ORs between both populations
and the original result. Thus, even though this SNP did not yield
the lowest P-value, it is potentially the best candidate for future
investigations. There are a number of other reasons for the lack of
replication, such as the use of different clinical definitions or that
different studies may be enriched in cases with different clinical
subtypes. This indicates that future GWAS or candidate gene
studies favorably would use much larger population sizes and more
careful phenotyping using strictly defined guidelines than what has
been used in the past. In addition, alternative strategies for the
identification of AR-associated genes, such as exome sequencing,
may be more successful strategies.
Materials and Methods
Ethics Statement
This study was approved by the Ethics Committee of the
Medical Faculty, Lund University and the Institutional Review
Board of National University of Singapore and written informed
consent was obtained from all subjects. This study is also in
compliance with the Helsinki declaration.
Study Populations and Phenotype Definitions
The Swedish study population was recruited at Malmo¨
University hospital (Malmo¨, Sweden) between the years 2003
and 2009 and consists of unrelated subjects from the general
population. It is comprised of 360 AR-cases (169 females, 191
males, mean age 33 years) and 720 controls (294 females, 426
males, mean age 43 years) with no atopy and allergic sympto-
mology. All cases were patients at the allergy clinic and were
diagnosed with symptomatic birch and/or timothy grass pollen
induced intermittent AR. Both cases and controls were of
Caucasian origin, with both parents born in Sweden. In the
Swedish population skin prick tests (SPT) [32] were performed
with a standard panel of 11 common airborne allergens (ALK-
Abello´, Hørsholm, Denmark). This study population has previ-
ously been analyzed in several AR studies [33,34,35].
The Singapore Chinese population was collected in Singapore
over multiple volunteer recruitment drives and consists of
unrelated subjects. In the Singapore Chinese population SPT
was using a panel consisting of common allergens in Singapore
such as Dermatophagoides pteronyssinus and Blomia tropicalis. The
population used in this study consists of 1024 AR cases (549
females, 475 males, mean age 22 years) with symptomatic dust
mite induced AR and 605 controls (449 females, 156 males, mean
age 22 years) with no atopy and allergic symptomology. This study
population has previously been analyzed in several AR studies
[4,35,36,37,38].
Diagnostic procedures for the study populations included
personal interview of medical history and SPT or Phadiatop tests
and were performed using standard panels of common airborne
allergens. SPT were performed on the volar side of the forearm
with saline buffer as negative and histamine chloride (10 mg/ml)
as positive controls. A wheal reaction diameter of $3 mm was
considered a positive SPT response. SPT was only performed if
the AR cases had not taken any anti-allergic drugs for at least 3
days prior to the test. Atopy is defined as a positive SPT reaction to
either one of allergens tested. AR is thus diagnosed based on the
presence of atopic status and typical AR symptoms as defined by
the Allergic Rhinitis Impact on Asthma (ARIA) guidelines i.e., two
or more AR symptoms (nasal congestion, rhinorrhea, nasal
itching, sneezing) persisting for four or more days per week
during the past year [1,39]. Conversely, the non-allergic controls
are defined by having no atopy and no typical AR symptoms.
Literature Mining and SNP Selection
PubMed (www.ncbi.nlm.nih.gov/pubmed/) was used to search
for reports on AR associations using the search terms: (rhinitis OR
hay fever) AND (association OR ‘‘case control’’) AND (polymor-
phism OR SNP OR mutation) AND English [language]. Studies
that only reported skin prick test scores, associations with severity
or related phenotypes such as IgE levels, but not allergic rhinitis per
se were not considered in this study. The first literature search was
conducted 2010-03-16 and served as a base for selection of 49
randomly chosen SNPs previously reported to be associated with
AR (P,0.05). A second literature search was made 2012-06-26,
using the same search terms as described above, to make an up-to-
date list containing all previously associated SNPs with AR (Table
S1 and S2).
Genotyping of Candidate Polymorphisms
Genomic DNA was extracted from blood collected in EDTA
using QIAamp DNA Blood Maxi or Mini kits (Qiagen, Hilden,
Germany) and DNA concentrations determined by fluorometry
using PicoGreen (Molecular Probes, Eugene, OR, USA). Geno-
types were determined using the Sequenom MassARRAY
MALDI-TOF system. The system analyzes allele-specific primer
extension products using mass-spectrometry. Assay design was
made using the MassARRAY Assay Design ver. 2.0 software
(Sequenom Inc, San Diego, CA, USA). Primers were obtained
from Metabion GmbH, Germany and all reactions were run
under the same conditions except for the primer annealing
temperature of the primary PCR. PCR reactions were performed
in a total volume of 6 ml containing 2.5 ng of template DNA,
1.25X HotStar Taq PCR buffer, 0.15 units of HotStar Taq
polymerase, 3.5 mMMgCl2, 0.5 mM dNTPs and 100 nM of each
primer. Amplifications were performed using GeneAmp 9700
machines with dual-384 heads as follows: 95uC for 15 min, 45
cycles of 95uC for 20 s, 56uC, 60uC or 64uC for 30 s, 72uC for 60 s
and finally 72uC for 3 min. Dephosphorylation of unincorporated
dNTPs was achieved using shrimp alkaline phosphatase. Concen-
trations of individual hME primer pairs were adjusted to even out
peak heights in the mass spectrum. The extension reactions were
then made by mixing the adjusted MassEXTEND primer mix
(containing approximately 1 mM of each primer) with hME
EXTEND mix containing buffer and 50 mM of each d/ddNTP
mix and 1.25 units of Thermo Sequenase. PCR amplification of
hME reactions was performed as follows: 94uC for 2 min and 99
cycles of 94uC for 5 s, 52uC for 5 s and 72uC for 5 s. The samples
were then manually desalted by using 6 mg of Clean Resin and a
dimple plate and subsequently transferred to a 384-well Spectro-
CHIP using a nanodispenser.
Analyzing 49 SNPs, the total genotyping rate in the Swedish
population was 99.4% in 352 (168 female, 184 male) cases and 709
(291 female, 418 male) controls after removal of low-quality DNA
samples. In the Chinese population, the total genotyping rate after
removal of low-quality data was 99.7% in 948 (514 female, 434
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male) cases and 580 (440 female, 140 male) controls. Only 45
SNPs were polymorphic in the Singapore Chinese population.
Statistical Analysis
Statistical analyses were made using R statistical software [40]
and the genetics package [41]. Genotype frequencies were
calculated and tested for Hardy-Weinberg equilibrium in both
cases and controls. Allele and genotype frequencies were then
investigated for association with AR using a x2-homogeneity test.
ORs and 95% confidence intervals were estimated by using the
most common allele as the referent and are reported for each
minor allele. The Kruskal-Wallis rank sum test was used for
analysis of associations between genotypes and SPT-scores. The
score is defined as the size of the wheel reaction in relation to
histamine. In order to compensate for the effect of multiple testing,
Q-values was calculated using the software QVALUE (ver.1.0)
[42]. One of the assumptions underlying the calculation of the Q-
values is that the P-values will be uniformly distributed under the
null hypothesis. We have calculated the number of expected P-
values in the different ranges, with a higher resolution for the
lower values.
Power calculations were made through simulations for the
association tests of allele effects. The calculations were made
separately for the Swedish and Singapore populations. For each
SNP we simulated a data set with the actual numbers of cases and
controls of the respective population, using the published or
calculated ORs (given published data) and the allele frequencies
observed in our populations. A total of 10 000 runs were made in
each case. For these, a full data set was simulated and the x2-value
was calculated. The number of times the test quantity exceeded
the critical values for 0.05 and 0.001 was subsequently scored.
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